Zimmer Biomet
Zimmer Biomet Holdings, Inc., commonly referred to as Zimmer Biomet, is a leading global medical device company headquartered in the United States. Founded in 1927, the company has established a strong presence in the orthopaedics and musculoskeletal sectors, focusing on innovative solutions for joint reconstruction, trauma, spine, and dental applications. With major operational regions across North America, Europe, and Asia-Pacific, Zimmer Biomet is renowned for its advanced products, including joint replacement implants and surgical instruments. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the healthcare industry. Notably, Zimmer Biomet's unique offerings, such as personalised surgical solutions and cutting-edge robotic technologies, enhance patient outcomes and streamline surgical procedures, solidifying its market leadership.
DitchCarbon Score
How does Zimmer Biomet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zimmer Biomet's score of 45 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zimmer Biomet's reported carbon emissions
In 2024, Zimmer Biomet reported total greenhouse gas emissions of approximately 101,910,000 kg CO2e for Scope 1 and about 67,195,000 kg CO2e for Scope 2 (market-based), resulting in a combined total of around 77,386,000 kg CO2e for Scope 1 and 2 emissions. This reflects a commitment to reducing absolute Scope 1 and 2 emissions by 55% by 2030, using 2017 as the baseline year. The company has also pledged to achieve net-zero greenhouse gas emissions across all scopes by 2050, formalised in September 2023 in collaboration with the Science Based Targets initiative (SBTi). Additionally, Zimmer Biomet aims to reduce Scope 3 emissions from purchased goods and services by 15% by 2030, based on 2019 levels. These initiatives position Zimmer Biomet as a proactive player in the healthcare equipment sector, aligning with industry standards for climate action and sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zimmer Biomet is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
